GLP-1 (glucagon-like peptide) medications, such as Ozempic and Wegovy, have seen a surge in popularity over the past few ...
Medicare currently only covers GLP-1s for diabetes and heart disease ... The intrigue: Employers and insurers are often on ...
Between 2023 and 2024, employer coverage of GLP-1s increased by 8%. Although some employers cover GLP-1 medications only for diabetes treatment, a growing number are reconsidering this policy.